Citation Impact
Citing Papers
Patterns of Cancer Incidence, Mortality, and Prevalence Across Five Continents: Defining Priorities to Reduce Cancer Disparities in Different Geographic Regions of the World
2006 Standout
CD73 Expression Is an Independent Prognostic Factor in Prostate Cancer
2015
Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update 2014
2015 Standout
Metastasis: from dissemination to organ-specific colonization
2009 Standout
Head and neck squamous cell carcinoma
2020 Standout
Kidney stones: pathophysiology and medical management
2006 Standout
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Recombinant Urate Oxidase (Rasburicase) in the Prophylaxis and Treatment of Tumor Lysis Syndrome
2004
Cytochrome P450 and the Individuality of Species
1999
Vascularized and functional human liver from an iPSC-derived organ bud transplant
2013 StandoutNature
Ribosome-inactivating proteins from plants
1993
Dietary Intake and Bioavailability of Polyphenols
2000 Standout
Twenty‐five years of clinical research for patients with limited‐stage small cell lung carcinoma in North America
2002
IVIg for Treatment of Severe Refractory Heparin-Induced Thrombocytopenia
2017
Risk factors for tumor lysis syndrome in patients with chronic lymphocytic leukemia treated with the cyclin-dependent kinase inhibitor, flavopiridol
2011
Antithrombotic Therapy for VTE Disease
2016 Standout
Genetic Polymorphisms of HumanN-Acetyltransferase, Cytochrome P450, Glutathione-S-Transferase, and Epoxide Hydrolase Enzymes: Relevance to Xenobiotic Metabolism and Toxicity
1999
Heparin-Induced Thrombocytopenia
1998
Prophylactic Cranial Irradiation for Patients with Small-Cell Lung Cancer in Complete Remission
1999
Lectins as Plant Defense Proteins
1995 Standout
Malignancies, Prothrombotic Mutations, and the Risk of Venous Thrombosis
2005 Standout
Cytochrome P450 complement (CYPome) of the avermectin-producer Streptomyces avermitilis and comparison to that of Streptomyces coelicolor A3(2)
2003 StandoutNobel
Prevention of VTE in Nonsurgical Patients
2012 Standout
Selection of large diversities of antiidiotypic antibody fragments by phage display
2002 StandoutNobel
Antithrombotic Therapy for VTE Disease
2012 Standout
Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer
2004 Standout
‘Mendelian randomization’: can genetic epidemiology contribute to understanding environmental determinants of disease?*
2003 Standout
T‐cell‐depleted allogeneic bone marrow transplantation for acute leukaemia using Campath‐1 antibodies and post‐transplant administration of donor's peripheral blood lymphocytes for prevention of relapse
1995
Autoimmune heparin‐induced thrombocytopenia
2017
The health-related quality of life and survival of small-cell lung cancer patients: Results of a companion study to CALGB 9033
2002
P450 enzymes and Parkinson's disease: The story so far
1998
Prevention of Venous Thromboembolism
2004 Standout
The Benefits of Frequent Positive Affect: Does Happiness Lead to Success?
2005 Standout
A Model to Select Chemotherapy Regimens for Phase III Trials for Extensive-Stage Small-Cell Lung Cancer
2000
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
2017 Standout
Treatment and Prevention of Heparin-Induced Thrombocytopenia
2012
Parkinson's Disease
1998 Standout
Tobacco Smoke Carcinogens and Lung Cancer
1999 Standout
Prevention of Venous Thromboembolism
2008 Standout
Paul Ehrlich's magic bullet concept: 100 years of progress
2008 Standout
Polymorphic Cytochrome P450 2D6: Humanized Mouse Model and Endogenous Substrates
2004
Update on Systemic Prostate Cancer Therapies: Management of Metastatic Castration-resistant Prostate Cancer in the Era of Precision Oncology
2018
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
Guidelines for the Prevention of Intravascular Catheter-related Infections
2011 Standout
Progress in understanding the molecular pathogenesis of human lung cancer
1998
Heparin-induced Thrombocytopenia, a Prothrombotic Disease
2007
Opportunities for Treg cell therapy for the treatment of human disease
2023 StandoutNobel
Recommendations for the evaluation of risk and prophylaxis of tumour lysis syndrome (TLS) in adults and children with malignant diseases: an expert TLS panel consensus
2010
The history and future of targeting cyclin-dependent kinases in cancer therapy
2015 Standout
Genetic metabolic polymorphisms and the risk of cancer: a review of the literature
1996
Flavopiridol administered using a pharmacologically derived schedule is associated with marked clinical efficacy in refractory, genetically high-risk chronic lymphocytic leukemia
2006
High-dose intravenous immunoglobulin for the treatment and prevention of heparin-induced thrombocytopenia: a review
2019
Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelines
2008 Standout
Epidemiology of Lung Cancer: Looking to the Future
2005
Etiology and management of tumor lysis syndrome in patients with chronic lymphocytic leukemia.
2009
Nanozymes: Classification, Catalytic Mechanisms, Activity Regulation, and Applications
2019 Standout
Current approaches to prevent and treat GVHD after allogeneic stem cell transplantation
2018
Cytochrome P450 2D6 variants in a Caucasian population: allele frequencies and phenotypic consequences.
1997
The Tumor Lysis Syndrome
2011 Standout
Efficacy and Safety of Rasburicase (recombinant urate oxidase) for the Prevention and Treatment of Hyperuricemia During Induction Chemotherapy of Aggressive Non-Hodgkin’s Lymphoma: Results of the GRAAL1 (Groupe d’Etude des Lymphomes de l’Adulte Trial on Rasburicase Activity in Adult Lymphoma) Study
2003
Factor V Leiden (G1691A) and Prothrombin Gene G20210A Mutations as Potential Risk Factors for Venous Thromboembolism after Total Hip or Total Knee Replacement Surgery
2002 StandoutNobel
Ipilimumab plus Lenalidomide after Allogeneic and Autologous Stem Cell Transplantation for Patients with Lymphoid Malignancies
2017 StandoutNobel
Guidelines for the Management of Pediatric and Adult Tumor Lysis Syndrome: An Evidence-Based Review
2008 Standout
MOLECULAR MECHANISMS OF GENETIC POLYMORPHISMS OF DRUG METABOLISM
1997
Rituximab Therapy in Hematologic Malignancy Patients With Circulating Blood Tumor Cells: Association With Increased Infusion-Related Side Effects and Rapid Blood Tumor Clearance
1999
Venous Thromboembolism and Cancer: Risks and Outcomes
2003
Long survival of patients with small cell lung cancer after adjuvant treatment with the anti-idiotypic antibody BEC2 plus Bacillus Calmette-Guérin.
1999
Nonmyeloablative Stem Cell Transplantation and Cell Therapy as an Alternative to Conventional Bone Marrow Transplantation With Lethal Cytoreduction for the Treatment of Malignant and Nonmalignant Hematologic Diseases
1998 Standout
Lutetium-177–PSMA-617 for Metastatic Castration-Resistant Prostate Cancer
2021 Standout
Relation of Factor V Leiden Genotype to Risk for Acute Deep Venous Thrombosis after Joint Replacement Surgery
1998
Cisplatin-Based Adjuvant Chemotherapy in Patients with Completely Resected Non–Small-Cell Lung Cancer
2004 Standout
Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination
2021 Standout
Development and validation of a predictive model for chemotherapy-associated thrombosis
2008 Standout
Comprehensive analysis of the genetic factors determining expression and function of hepatic CYP2D6
2001
Pharmacogenomics: Translating Functional Genomics into Rational Therapeutics
1999 StandoutScience
Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 Vaccination
2021 Standout
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
Mechanism of Oxidation Reactions Catalyzed by Cytochrome P450 Enzymes
2004 Standout
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Argatroban Anticoagulant Therapy in Patients With Heparin-Induced Thrombocytopenia
2001 Standout
Nonmyeloablative Stem Cell Transplantation and Cell Therapy as an Alternative to Conventional Bone Marrow Transplantation With Lethal Cytoreduction for the Treatment of Malignant and Nonmalignant Hematologic Diseases
1998 Standout
American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003
2003 Standout
Engineering Chemical Reactivity on Cell Surfaces Through Oligosaccharide Biosynthesis
1997 StandoutScienceNobel
Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination
2021 Standout
Works of James N. Frame being referenced
Systemic Therapy in Men With Metastatic Castration-Resistant Prostate Cancer: American Society of Clinical Oncology and Cancer Care Ontario Clinical Practice Guideline
2014
Clinical significance of the FV:Q506 mutation in unselected oncology patients
1996
Correction of Severe Heparin-Associated Thrombocytopenia with Intravenous Immunoglobulin
1989
COMPARISON OF CAMPATH-1 PLUS COMPLEMENT, ANTI-T CELL RICIN A CHAIN IMMUNOTOXIN, AND SOYBEAN AGGLUTININ ALONE OR IN COMBINATION WITH SHEEP ERYTHROCYTES OR IMMUNOMAGNETIC BEADS
1989
Patients with limited-stage small-cell lung cancer treated with concurrent twice-daily chest radiotherapy and etoposide/cisplatin followed by cyclophosphamide, doxorubicin, and vincristine.
1996
Outcome of Patients With Small-Cell Lung Cancer During 20 Years of Clinical Research at the US National Cancer Institute
1997
The Heparin-Induced Thrombocytopenia Task Force Model: Implementing Quality Improvement and Economic Outcome Initiatives
2005
Tumor lysis syndrome: an uncommon complication of fludarabine therapy of chronic lymphocytic leukemia.
1998
Identification of a new variant CYP2D6 allele with a single base deletion in exon 3 and its association with the poor metabolizer phenotype
1994
A Randomized, Open-Label Pilot Study Comparing Desirudin and Argatroban in Patients With Suspected Heparin-Induced Thrombocytopenia With or Without Thrombosis: PREVENT-HIT Study
2010
Outcome of Patients With Small-Cell Lung Cancer During 20 Years of Clinical Research at the US National Cancer Institute
1997
Genetic polymorphism of CYP2D6 and lung cancer risk
1994
Debrisoquine metabolism and lung cancer risk.
1995